文献速递牙体牙髓病儿童口腔

仿生P11-4自组装肽对非龋洞性龋损的再矿化潜力:一项评估半标准化前后X线片的回顾性队列研究

Remineralizing potential of the biomimetic P11-4 self-assembling peptide on noncavitated caries lesions: A retrospective cohort study evaluating semistandardized before-and-after radiographs.
PubMed 文献 · J Am Dent Assoc · 2023-08-28

该回顾性队列研究评估了仿生自组装肽P11-4在真实临床环境中对恒牙早期龋损的再矿化效果。结果显示37%的RA1、38%的RA2和40%的RA3期龋损出现回归,无空洞病损比例在1年后为0.96、2年后为0.91。

要点

  • P11-4自组装肽可使恒牙早期邻面龋损出现分期回归,RA1、RA2、RA3期回归率分别为37%、38%、40%。
  • 治疗后无空洞病损比例较高:1年时为0.96(95%CI 0.94-0.98),2年时为0.91(95%CI 0.88-0.95)。
  • P11-4是治疗恒牙早期龋损的安全方法,可促进病损最深区域再矿化,易于融入常规牙科实践。

核心结论

  • 真实世界临床数据表明,自组装肽P11-4可促使早期龋损恢复并改善牙齿分期。

主要发现

  • 37%的RA1期龋损出现回归(95%CI 31%-44%)。
  • 38%的RA2期龋损出现回归(95%CI 30%-45%)。
  • 40%的RA3期龋损出现回归(95%CI 16%-68%)。
  • 无空洞病损比例在1年后为0.96(95%CI 0.94-0.98),2年后为0.91(95%CI 0.88-0.95)。

临床怎么用

  • P11-4可用于恒牙早期龋损的治疗,促进病损深层再矿化,且易于引入常规牙科实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Self-assembling peptide (SAP) P11-4 was introduced to treat initial caries lesions by means of guiding hydroxyapatite regeneration within the lesion. The objective of this study was to assess its effectiveness in a practical clinical setting. METHODS: Caries lesions in permanent teeth treated with monomeric and polymeric SAP P11-4 from May 2015 through October 2020 were retrospectively analyzed at lesion and child levels by means of bite-wing radiography for changes in stage and cavitation and restoration. RESULTS: Two hundred and nineteen children aged 10 through 19 years with a total of 405 proximal lesions in posterior teeth were followed from 0.4 through 5.5 years (median, 7 months; interquartile range, 6-19 months). Regression occurred in 37% of stage RA1 (radiolucency in the outer one-half of enamel) (95% CI, 31% to 44%), 38% of stage RA2 (radiolucency in the inner one-half of enamel plus or minus the enamel-dentin junction) (95% CI, 30% to 45%), and 40% of stage RA3 (radiolucency limited to the outer one-third of dentin) (95% CI, 16% to 68%) lesions. The proportion of lesions with no cavitation was 0.96 (95% CI, 0.94 to 0.98) after 1 year and 0.91 (95% CI, 0.88 to 0.95) after 2 years. CONCLUSIONS: Real-world clinical data indicate that SAP P11-4 can lead to recovery and a healthier tooth stage. PRACTICAL IMPLICATIONS: SAP P11-4 is a safe treatment for initial caries lesions in permanent teeth that remineralizes in the deepest zone of the lesion and can be introduced easily into routine dental practice.

来源:J Am Dent Assoc,查看原文。版权归原作者所有。

引用

  1. Godenzi D, Bommer C, Heinzel-Gutenbrunner M, et al. Remineralizing potential of the biomimetic P11-4 self-assembling peptide on noncavitated caries lesions: A retrospective cohort study evaluating semistandardized before-and-after radiographs. J Am Dent Assoc. 2023. PMID: 37642611. doi:10.1016/j.adaj.2023.07.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。